Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 42Cyclophosphamide 37Busulfan 31Cyclosporine 30Peripheral Blood Stem Cell Transplantation 29Cytarabine 27Mycophenolic Acid 25Antilymphocyte Serum 23Filgrastim 22Methotrexate 20Whole-Body Irradiation 18Radiotherapy 17Tacrolimus 16Methylprednisolone 13Etoposide 12Cord Blood Stem Cell Transplantation 12Melphalan 11Daunorubicin 10sargramostim 8fludarabine 8Idarubicin 8Granulocyte Colony-Stimulating Factor 8Thiotepa 6Cyclosporins 6tipifarnib 5merphos 5Topotecan 5Mitoxantrone 5Gemtuzumab 5Azacitidine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anemia, Refractory, with Excess of Blasts × Amsacrine × Clear all
NCT00003436 2013-12-04

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Completed
2,000 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡